Search Login Register

Necrolytic Migratory Erythema Summary

Description: Recurrent cutaneous manifestation of GLUCAGONOMA characterized by necrolytic polycyclic migratory lesions with scaling borders. It is associated with elevated secretion of GLUCAGON by the tumor. Other conditions with elevated serum glucagon levels such as HEPATIC CIRRHOSIS may also result in similar skin lesions, which are referred to as pseudoglucagonoma syndrome.

Also Known As: Erythema, Necrolytic Migratory; Erythemas, Necrolytic Migratory; Migratory Erythema, Necrolytic; Migratory Erythemas, Necrolytic; Necrolytic Migratory Erythemas Show All >>

Networked: 109 relevant articles (4 outcomes, 1 trials/studies) for this Disease

Key Drugs and Agents for Necrolytic Migratory Erythema

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Glucagon (Glukagon) : 3 outcomes in 41 results : FDA 4
  2. Octreotide (Sandostatin) : 1 outcome in 8 results : FDA 14 Generic
  3. Somatostatin (Somatotropin Release-Inhibiting Factor) : 1 outcome in 6 results : IBA
  4. Glucose (Dextrose) : 1 outcome in 3 results : FDA 175 Generic
  5. Glucagon-Like Peptides (Enteroglucagon) : 1 outcome in 1 result : IBA
  6. Glucagonoma syndrome : 1 study in 51 results : IBA
  7. Zinc : 13 results : IBA
  8. Acrodermatitis enteropathica : 5 results : IBA
  9. Insulin (Novolin) : 4 results : FDA 2
  10. Amino Acids : 2 results : FDA 53
Show All >>

Diseases Related to Necrolytic Migratory Erythema

  1. Neoplasms (Cancer)
  2. Exanthema (Rash)
  3. Diarrhea
  4. Weight Gain
  5. Type 1 Diabetes Mellitus (Autoimmune Diabetes)
Show All >>

Key Therapies for Necrolytic Migratory Erythema

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 2 results
  2. Liver Transplantation : 1 result
  3. Total Parenteral Nutrition : 1 result
  4. Injections : 1 result

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.